University of Maryland Eastern Shore School of Pharmacy and Health Professions, Princess Anne, MD.
Capital Health Medical Center, Pennington, NJ.
Am J Health Syst Pharm. 2020 Sep 4;77(18):1488-1496. doi: 10.1093/ajhp/zxaa198.
To determine the attitudes and perceptions of pharmacy residency program participants regarding proposed expansion of postgraduate year 3 (PGY3) residency training opportunities.
An online questionnaire was emailed to all directors of ASHP-accredited residency programs with a request to distribute the survey among program participants, including residents, preceptors, coordinators, and other pharmacists working with residents. Survey questions assessed participants' views and attitudes about PGY3 programs vs other avenues of career advancement, including potential benefits and limitations, program structure, and ramifications for the profession.
Eight hundred forty-five individuals participated in the survey, for a 22.47% response rate. Only 288 pharmacists (34.4%) were familiar with the PGY3 residency training concept. Perceived benefits of PGY3 training, by percentage of respondents citing them, included job specialization (34.41%), an additional year of training (19.93%), and obtaining research skills (5.44%). The main perceived limiting factors included personal finances (21.62%), lack of justification for PGY3 training (13.83%), and time commitments (12.94%). As alternatives to PGY3 training for career advancement, board certifications (49.5%), scholarly activity (19.8%), and leadership in pharmacy organizations (19.2%) were the 3 highest-rated areas. A majority of respondents were opposed to ASHP standardization of PGY3 residency programs (74.3%) and/or had negative preconceptions of the potential impact of expanded PGY3 training initiatives on the job market (80.94%).
Overall, surveyed pharmacy residency program participants were opposed to the concept of expanded PGY3 training initiatives and indicated their view that PGY3 training offers limited benefits in terms of professional development. Participants favored on-the-job training and other avenues of career advancement over PGY3 residency training.
确定药房住院医师培训计划参与者对拟议扩大研究生第 3 年（PGY3）住院医师培训机会的态度和看法。
向所有 ASHP 认可的住院医师培训计划主任发送电子邮件，要求他们在计划参与者中分发调查，包括住院医师、导师、协调员和与住院医师一起工作的其他药剂师。调查问题评估了参与者对 PGY3 计划与其他职业发展途径的看法和态度，包括潜在的好处和限制、计划结构以及对专业的影响。
845 人参与了调查，回复率为 22.47%。只有 288 名药剂师（34.4%）熟悉 PGY3 住院医师培训概念。按受访者百分比计算，PGY3 培训的感知收益包括工作专业化（34.41%）、额外一年的培训（19.93%）和获得研究技能（5.44%）。主要感知的限制因素包括个人财务（21.62%）、缺乏 PGY3 培训的理由（13.83%）和时间承诺（12.94%）。作为职业发展的 PGY3 培训替代方案，委员会认证（49.5%）、学术活动（19.8%）和药房组织的领导力（19.2%）是评分最高的三个领域。大多数受访者反对 ASHP 对 PGY3 住院医师培训计划的标准化（74.3%），并且/或者对扩大 PGY3 培训计划对就业市场的潜在影响持有负面先入之见（80.94%）。
总体而言，参与调查的药房住院医师培训计划参与者反对扩大 PGY3 培训计划的概念，并表示他们认为 PGY3 培训在专业发展方面提供的收益有限。参与者赞成在职培训和其他职业发展途径，而不是 PGY3 住院医师培训。
